Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development-Reference-Cited by-同舟云学术

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development

Published:2009-06 Issue:6 Volume:48 Page:455-467
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Missiaglia Edoardo,Selfe Joanna,Hamdi Mohamed,Williamson Daniel,Schaaf Gerben,Fang Cheng,Koster Jan,Summersgill Brenda,Messahel Boo,Versteeg Rogier,Pritchard-Jones Kathy,Kool Marcel,Shipley Janet

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference54 articles.

1. Genes, chromosomes, and rhabdomyosarcoma;Anderson;Genes Chromosomes Cancer,1999

2. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes;Banks;Cell Cycle,2006

3. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes;Bridge;Genes Chromosomes Cancer,2002

4. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones;Clark;Genes Chromosomes Cancer,2002

5. Misexpression of the eyes absent family triggers the apoptotic program;Clark;J Biol Chem,2002

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancers;2024-02-29

2. Growth factors reviews;Fibroblast Growth Factors;2024

3. Prognostic implications of FGFR3high/Ki-67high in oral squamous cell carcinoma;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-09

4. Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study;Clinical Cancer Research;2023-08-22

5. Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers;Oncogene;2023-05-02